Premature battery depletion of an insertable cardiac monitor: A 2-patient case series
Year: 2026
Type: article
Study design: Case Report
Abstract: The Abbott Assert-IQ EL+ (DM5500; Abbott Medical, Sylmar, CA) is a Bluetooth-enabled insertable cardiac monitor (ICM) that received U.S. Food and Drug Administration (FDA) clearance in 2023.1 Its rated 6-year battery longevity is the longest among currently available ICM devices.1 ICMs enable detection of clinically significant atrial and ventricular arrhythmias, including surveillance across post-ablation monitoring periods, long-term cryptogenic stroke evaluation, and atrial arrhythmia burden.
Source: HeartRhythm Case Reports
Institution: University of California San Diego
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $1,100
OpenAlex ID: W7201860175
